>>> US Research Calls I

Research Calls I
  • Upgrades:
    • AeroVironment (AVAV) upgraded to Market Perform from Underperform at Raymond James
    • APA Corp. (APA) upgraded to Equal Weight from Underweight at Barclays, tgt $35
    • Banco Santander (SAN) upgraded to Overweight from Equal Weight at Morgan Stanley
    • Brookfield Infrastructure Partners (BIP) upgraded to Overweight at Morgan Stanley, tgt $45
    • Celldex Therapeutics (CLDX) upgraded to Outperform from Peer Perform at Wolfe Research, tgt $44
    • Cheniere Energy (LNG) upgraded to Overweight from Equal Weight at Morgan Stanley, tgt $313
    • Colony Bankcorp (CBAN) upgraded to Buy from Neutral at Brean Capital
    • MongoDB (MDB) upgraded to Outperform from Neutral at Mizuho, tgt $325
    • MoonLake Immunotherapeutics (MLTX) upgraded to Outperform from Underperform at Wolfe Research, tgt $24
    • Valvoline (VVV) upgraded to Buy from Hold at Stifel, tgt $42
    • Venture Global (VG) upgraded to Overweight from Underweight at Morgan Stanley, tgt $22
  • Downgrades:
    • AvePoint (AVPT) downgraded to Market Perform from Outperform at William Blair
    • Backblaze (BLZE) downgraded to Underperform from Outperform at William Blair
    • Beiersdorf (BDRFF) downgraded to Hold from Buy at Berenberg
    • Box (BOX) downgraded to Mkt Perform from Outperform at William Blair
    • Brookfield Infrastructure (BIPC) downgraded to Underweight at Morgan Stanley, tgt $45
    • Brookfield Renewable (BEPC) downgraded to Underweight at Morgan Stanley, tgt $42
    • China Eastern Airlines (CEA) downgraded to Underweight from Neutral at JPMorgan
    • Commvault Systems (CVLT) downgraded to Market Perform from Outperform at William Blair
    • Crown Castle (CCI) downgraded to Equal Weight from Overweight at Wells Fargo, tgt $85
    • Dropbox (DBX) downgraded to Underperform from Mkt Perform at William Blair
    • GitLab (GTLB) downgraded to Underperform from Outperform at William Blair
    • Gossamer Bio (GOSS) downgraded to Neutral from Overweight at Cantor Fitzgerald
    • ING Groep (ING) downgraded to Equal Weight from Overweight at Morgan Stanley
    • Mereo BioPharma (MREO) downgraded to Neutral from Overweight at JPMorgan
    • N-able (NABL) downgraded to Underperform from Outperform at William Blair
    • National Grid (NGG) downgraded to Neutral from Buy at Goldman
    • Nutanix (NTNX) downgraded to Market Perform from Outperform at William Blair
    • PG&E (PCG) downgraded to Hold from Buy at Jefferies, tgt $19
    • SSE (SSEZY) downgraded to Neutral from Buy at Goldman
    • Super Micro Computer (SMCI) downgraded to Market Perform from Outperform at Northland, tgt $22
    • Thomson Reuters (TRI) downgraded to Equal Weight from Overweight at Wells Fargo, tgt $95
    • Varonis Systems (VRNS) downgraded to Market Perform from Outperform at William Blair
    • XPeng (XPEV) downgraded to Neutral from Outperform at Macquarie, tgt $19
    • Zimmer Biomet (ZBH) downgraded to Neutral from Buy at BTIG Research
  • Others:
    • Climb Global Solutions (CLMB) initiated with an Outperform at Northland Capital; tgt $32
    • Eupraxia Pharmaceuticals (EPRX) initiated with an Outperform at William Blair
    • Hut 8 Mining (HUT) initiated with a Buy at Arete; tgt $136
    • Jasper Therapeutics (JSPR) assumed with a Neutral at UBS, tgt $1.50
    • MTN Group (MTNOY) initiated with a Buy at UBS
    • Odysight.ai (ODYS) initiated with a Buy at Benchmark, tgt $10
    • Red Rock Resorts (RRR) initiated with a Buy at Benchmark, tgt $67
    • TeraWulf (WULF) initiated with a Buy at Arete, tgt $30
    • Vodacom (VDMCY) initiated with a Neutral at UBS